V symptoms and
appearance

Treatment arm
of an RCT
followed up to
1 year (VANISH2)

King,
2015208

279 patients (C2:
49.1%, C3-C6:
50.9%)

PEM 0.125%, 0.5%,
1%, 2% for GSV
reï¬‚ux or varicose
tributaries

Placebo

RCT